Shumpei Yokota Selected Research

Juvenile Arthritis (Juvenile Idiopathic Arthritis)

3/2021	Safety and effectiveness of adalimumab in Japanese patients with juvenile idiopathic arthritis: Results from a real-world postmarketing study.
1/2021	Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis: 48-week results from an open-label phase III study in Japanese patients.
4/2019	Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study.
1/2018	Safety and effectiveness of etanercept for treatment of juvenile idiopathic arthritis: Results from a postmarketing surveillance.
1/2017	PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis.
1/2016	Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan.
4/2015	Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab.
1/2015	Pathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome".
7/2014	Effect of tocilizumab on growth impairment in systemic juvenile idiopathic arthritis with long-term corticosteroid therapy.
6/2014	Discrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shumpei Yokota Research Topics

Disease

42	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 03/2021 - 09/2003
12	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2017 - 01/2004
11	Infections 02/2021 - 12/2002
10	Inflammation (Inflammations) 02/2021 - 12/2002
10	Fever (Fevers) 01/2015 - 09/2003
8	Rheumatic Diseases (Rheumatism) 05/2016 - 04/2002
8	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2015 - 04/2002
8	Disease Progression 12/2013 - 09/2003
7	Arthritis (Polyarthritis) 01/2018 - 09/2003
7	Macrophage Activation Syndrome 04/2015 - 09/2003
7	Leukemia 01/2014 - 10/2003
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2013 - 10/2003
5	Cryopyrin-Associated Periodic Syndromes 11/2017 - 01/2012
4	Cytokine Release Syndrome 02/2021 - 11/2003
4	Takayasu Arteritis (Arteritis, Takayasu's) 01/2020 - 01/2010
4	Rheumatoid Arthritis 01/2017 - 04/2002
4	Dermatomyositis (Dermatopolymyositis) 12/2015 - 12/2002
4	Chorioamnionitis 10/2014 - 07/2003
4	Neoplasms (Cancer) 01/2014 - 06/2004
3	Tuberculosis (Tuberculoses) 05/2016 - 12/2005
3	Lupus Nephritis 03/2015 - 04/2002
3	Asthma (Bronchial Asthma) 12/2012 - 04/2007
3	Human Influenza (Influenza) 11/2012 - 04/2007
3	Proteinuria 08/2010 - 04/2007
3	Lung Diseases (Lung Disease) 04/2010 - 07/2003
3	Abdominal Pain (Pain, Abdominal) 01/2010 - 06/2006
3	Hypersensitivity (Allergy) 04/2007 - 09/2004
2	Communicable Diseases (Infectious Diseases) 02/2021 - 01/2012
2	Polyarteritis Nodosa (Periarteritis Nodosa) 07/2018 - 10/2008
2	Melanoma (Melanoma, Malignant) 12/2015 - 05/2015
2	Muscular Diseases (Myopathy) 05/2014 - 11/2012
2	Pain (Aches) 08/2013 - 01/2013
2	Drug-Related Side Effects and Adverse Reactions 05/2013 - 12/2005
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 02/2013 - 02/2008
2	Body Weight (Weight, Body) 11/2012 - 01/2005
2	Muscle Weakness 11/2012 - 12/2002
2	Congenital Heart Defects (Congenital Heart Defect) 01/2012 - 06/2010
2	Anemia 09/2010 - 10/2008
2	Calcinosis 02/2010 - 06/2003
2	Neuroblastoma 07/2008 - 01/2008
2	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2008 - 07/2006
2	Lymphoma (Lymphomas) 10/2007 - 10/2003

Drug/Important Bio-Agent (IBA)

24	tocilizumab (atlizumab)FDA Link 01/2020 - 03/2005
12	SteroidsIBA 01/2020 - 09/2003
9	CytokinesIBA 02/2021 - 01/2004
9	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016 - 09/2003
9	Interleukin-6 (Interleukin 6)IBA 01/2014 - 09/2003
8	Monoclonal AntibodiesIBA 01/2015 - 12/2008
8	Pharmaceutical PreparationsIBA 12/2013 - 04/2002
7	C-Reactive ProteinIBA 04/2019 - 03/2007
7	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2014 - 07/2006
7	Prednisolone (Predate)FDA LinkGeneric 12/2013 - 04/2002
6	canakinumab FDA Link 01/2021 - 01/2012
6	Biological ProductsIBA 07/2018 - 07/2007
6	Intravenous Immunoglobulins (IVIG)FDA Link 04/2015 - 02/2007
6	Methylprednisolone FDA LinkGeneric 05/2014 - 10/2005
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2014 - 12/2002
6	Methotrexate (Mexate)FDA LinkGeneric 01/2014 - 01/2005
5	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020 - 09/2003
5	Immunosuppressive Agents (Immunosuppressants)IBA 07/2018 - 10/2003
5	Etanercept (Enbrel)FDA Link 01/2018 - 01/2005
5	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2005
5	AntibodiesIBA 05/2015 - 06/2006
5	Infliximab (Remicade)FDA Link 01/2015 - 12/2008
4	Adalimumab (Humira)FDA Link 03/2021 - 08/2012
4	mizoribineIBA 02/2009 - 04/2002
4	gamma-Globulins (gamma-Globulin)IBA 02/2007 - 01/2004
3	fibrin fragment D (D-dimer)IBA 04/2015 - 10/2008
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2015 - 02/2008
3	EnzymesIBA 08/2013 - 12/2002
3	Indicators and Reagents (Reagents)IBA 08/2012 - 01/2005
3	Immunoglobulins (Immunoglobulin)IBA 02/2012 - 05/2004
3	Prostaglandins EIBA 01/2012 - 11/2006
3	Alanine Transaminase (SGPT)IBA 02/2011 - 03/2006
3	DNA (Deoxyribonucleic Acid)IBA 08/2010 - 05/2004
3	anti-dsDNA autoantibodyIBA 08/2010 - 06/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2010 - 12/2008
3	Glutathione (Reduced Glutathione)IBA 07/2008 - 10/2003
2	Oligonucleotide ProbesIBA 01/2017 - 03/2011
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2017 - 09/2004
2	InterferonsIBA 05/2016 - 10/2008
2	Proteins (Proteins, Gene)FDA Link 10/2014 - 06/2006
2	Signal Recognition ParticleIBA 05/2014 - 11/2012
2	InterleukinsIBA 05/2013 - 08/2009
2	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2013 - 12/2002
2	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2012 - 04/2007
2	Hyaluronic Acid (Hyaluronan)IBA 01/2012 - 09/2007
2	Antirheumatic Agents (DMARD)IBA 12/2011 - 04/2010
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 04/2009 - 11/2004
2	Interferon-gamma (Interferon, gamma)IBA 02/2009 - 12/2005
2	beta 2-Microglobulin (beta 2 Microglobulin)IBA 10/2008 - 07/2003
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2008 - 10/2003

Therapy/Procedure

34	Therapeutics 05/2016 - 04/2002
8	Plasma Exchange 05/2014 - 01/2004
5	Drug Therapy (Chemotherapy) 10/2011 - 06/2004
3	Hematopoietic Stem Cell Transplantation 01/2018 - 01/2008
2	Aftercare (After-Treatment) 07/2013 - 09/2004
2	Transplantation 03/2008 - 02/2008
2	Stem Cell Transplantation 01/2008 - 07/2006
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2008 - 07/2006